Английская Википедия:Eleanor Barnes

Материал из Онлайн справочника
Версия от 18:58, 2 марта 2024; EducationBot (обсуждение | вклад) (Новая страница: «{{Английская Википедия/Панель перехода}} {{Short description|British physician}} {{Use dmy dates|date=April 2022}} {{Third-party|date=September 2021}} {{Infobox scientist | name = Eleanor Barnes | workplaces = John Radcliffe Hospital <br /> University of Oxford | alma_mater = University of Oxford <br /> St Bartholomew's Hospital | thesis_title = T-cell and dendritic cell function an...»)
(разн.) ← Предыдущая версия | Текущая версия (разн.) | Следующая версия → (разн.)
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Use dmy dates Шаблон:Third-party Шаблон:Infobox scientist Eleanor Barnes is a British physician at the John Radcliffe Hospital and a Professor of Hepatology and Experimental Medicine at the University of Oxford. She has studied hepatitis C and the development of the development of HCV vaccines. She is a Fellow of the Academy of Medical Sciences and serves as the lead for hepatology at the National Institute for Health Research (NIHR) Clinical Research Network.[1]

Early life and education

Barnes has said that she was interested in science as a child.[2] She decided to study medicine at university, and eventually trained at St Bartholomew's Hospital.[2] She completed an intercalated bachelor's degree in anthropology and philosophy.[2] After graduating, she worked as a medical resident at the Royal Free Hospital, where she decided to specialise in hepatology and gastroenterology. Determined to pursue a career in research, Barnes worked unpaid for three months, during which time she obtained data that she used to apply for a fellowship from the Medical Research Council.[3] She was a doctoral researcher at the University of Oxford. Her doctoral research considered T cell and dendritic cell function.[4]

Research and career

Barners' research considers T cell immunology. She is focused on the translation of laboratory findings to clinical environments. Barnes worked as a Medical Research Council Senior Fellow at the University of Oxford, and eventually was appointed lead of herpetology in the Thames Valley.[5][6] She studied why 80% of patients with hepatitis C get chronic infection.[5] Barnes identified that the nature of the T cell response determines which pathway a patient goes down. This observation led Barnes to develop an T-cell vaccine to prevent hepatitis C infection. The vaccine is based on adenoviral vectors, which host the non-structural proteins of hepatitis C from a genotype 1B strain.[5] There are seven major hepatitis C strains, which presents considerable challenges for the development of vaccines.[5] Barnes was elected Fellow of the Academy of Medical Sciences in 2018.[7]

During the COVID-19 pandemic, Barnes studied the design, effectiveness and implementation of the COVID-19 vaccine.[8] She showed that patients who suffered from COVID-19 were likely to be impacted by liver problems.[9]

Selected publications

Personal life

Barnes is married with two children.[5]

References

Шаблон:Reflist

Шаблон:Authority control